Efficacy of therapeutic intervention with an oral ether–lipid analogue of cidofovir (CMX001) in a lethal mousepox model

In the 21st century we are faced with the potential use of natural or recombinant VARV and MPXV as biological weapons, and the emergence of human MPXV. Such an occurrences would require therapeutic and prophylactic intervention with antivirals. Cidofovir, an antiviral approved for the treatment of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Scott, Touchette, Erin, Oberle, Christina, Almond, Merrick, Robertson, Alice, Trost, Lawrence C., Lampert, Bernhard, Painter, George, Buller, R. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628989/
https://www.ncbi.nlm.nih.gov/pubmed/17904231
http://dx.doi.org/10.1016/j.antiviral.2007.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628989/
https://www.ncbi.nlm.nih.gov/pubmed/17904231
http://dx.doi.org/10.1016/j.antiviral.2007.08.003

Ejemplares similares